Soligenix, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Soligenix, Inc. Common Stock (SNGX) has a 3-month relative strength percentile of 3 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 27. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 10.1%, relative volume 0.16×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
SNGX is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -30.3% / -66.5%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
SNGX appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $69K notional.
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $69K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SNGX Jan avg: -8.55% median: -9.12% win: 0% σ: 4.99% n: 4 2022-04-12 → 2026-05-29 | SNGX Feb avg: -12.96% median: -3.23% win: 25% σ: 28.14% n: 4 2022-04-12 → 2026-05-29 | SNGX Mar avg: -14.90% median: -12.31% win: 0% σ: 15.24% n: 4 2022-04-12 → 2026-05-29 | SNGX Apr avg: -33.09% median: -29.49% win: 0% σ: 23.31% n: 5 2022-04-12 → 2026-05-29 | SNGX May avg: 19.21% median: -4.06% win: 40% σ: 84.08% n: 5 2022-04-12 → 2026-05-29 | SNGX Jun avg: -19.36% median: -16.43% win: 25% σ: 24.82% n: 4 2022-04-12 → 2026-05-29 (current) | SNGX Jul avg: 55.60% median: 54.54% win: 75% σ: 55.17% n: 4 2022-04-12 → 2026-05-29 | SNGX Aug avg: -12.72% median: -13.99% win: 25% σ: 14.35% n: 4 2022-04-12 → 2026-05-29 | SNGX Sep avg: -17.28% median: -15.22% win: 50% σ: 42.42% n: 4 2022-04-12 → 2026-05-29 | SNGX Oct avg: 17.13% median: 13.03% win: 50% σ: 33.44% n: 4 2022-04-12 → 2026-05-29 | SNGX Nov avg: 19.97% median: -3.07% win: 50% σ: 56.46% n: 4 2022-04-12 → 2026-05-29 | SNGX Dec avg: -19.35% median: -19.46% win: 0% σ: 2.87% n: 4 2022-04-12 → 2026-05-29 |